BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 8, 2002
View Archived Issues
Narrowing Focus To Three Drugs, EntreMed Makes Reductions
Read More
Changeable Chromosomal Gene Expression Patterns Foretell Fate, Relapse Or Cure In Wilms' Tumor
Read More
Completed Phase III Enrollment Brings Eyetech Rest Of $108.5M
Read More
Other News To Note
Read More
Appointments And Advancements
Read More
Feeling Biotech's Money Woes, Targeted Genetics Cuts Back
Tenuous economic conditions have prompted Targeted Genetics Corp. to reduce expenses by eliminating jobs and placing certain projects on the backburner, the company's president and CEO said. (BioWorld Today)
Read More